Penumbra (PEN) Other Non-Current Liabilities (2014 - 2026)
Penumbra (PEN) posted quarterly Other Non-Current Liabilities of $14.2 million for Q2 2026, down 20.03% year-over-year from $17.8 million in Q2 2025, and up 7.54% quarter-over-quarter from $13.2 million in Q1 2026.
Penumbra (PEN) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Other Non-Current Liabilities for 13 consecutive years, with $14.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 20.03% year-over-year to $14.2 million; the TTM figure through Jun 2026 stood at $14.2 million (down 20.03% YoY), while the FY2025 annual figure was $12.3 million, down 18.46% from the prior year.
- Other Non-Current Liabilities rose to $14.2 million in Q2 2026 per PEN's latest filing, from $13.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $17.8 million in Q2 2025 and bottomed at $3.2 million in Q1 2023.
- Historically, Other Non-Current Liabilities has averaged $8.6 million across 5 years, with a median of $6.7 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 56.84% — and 2024, when it soared 189.53%.
- Penumbra's Other Non-Current Liabilities stood at $3.3 million in 2022, then jumped by 62.03% to $5.3 million in 2023, then soared by 184.59% to $15.1 million in 2024, then retreated by 18.46% to $12.3 million in 2025, then increased by 15.68% to $14.2 million in 2026.
- Business Quant data shows PEN's Other Non-Current Liabilities at $14.2 million in Q2 2026, $13.2 million in Q1 2026, and $12.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 13.25 Mn |
| Dec 31, 2025 | 12.32 Mn |
| Sep 30, 2025 | 14.53 Mn |
| Jun 30, 2025 | 17.82 Mn |
| Mar 31, 2025 | 15.94 Mn |
| Dec 31, 2024 | 15.11 Mn |
| Sep 30, 2024 | 9.45 Mn |
| Jun 30, 2024 | 7.62 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 3.29 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 3.30 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 3.56 Mn |
| Sep 30, 2021 | 7.64 Mn |